# AbbVie inks $10.9B Apogee buyout to bag eczema prospect

> **Open Intelligence Dossier** · First detected: 2026-06-23 07:07 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"AbbVie inks $10.9B Apogee buyout to bag eczema prospect" is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include The Business Journals and FirstWord Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| The Business Journals | AbbVie seals $10.9B deal to acquire Waltham biotech Apogee Therapeutics | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxPQXJQRFRxdGdSYm9SZ2t4aDNKcnZlalNpMGw4VmxwV2N6Q25nSWprN1hUNEtRWE01Vllybl9JNTMxcUF1VjVHX1IwNFo5aVZjTS12dEdkSF9jZDV4VGs1UWJSNWxoMkl1TTBPMEtPZWdHYXFrRERnbjVYbTV6eGxsTUpUOTBaUnNrMzlvV3hEWUI5emRnMWtVREVkR2dqdG8za1hnczMxLXo?oc=5) |
| FirstWord Pharma | AbbVie said to be reeling in Apogee and its Dupixent rival for almost $11B: report | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE9CQU9yeEROTlNfM2dKNEwxWlAwRDNYN3d6Um41Mm5pSE5mM2p4M2NteExkcDV4eUJnbWYxeFFadThhenpCZTI5Z3poSWdZdDdoYW9Z?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-23/abbvie-inks-10-9b-apogee-buyout-to-bag-eczema-prospect*